Page last updated: 2024-08-24

epigallocatechin gallate and Carcinoma, Lewis Lung

epigallocatechin gallate has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, YL; Lai, YJ; Li, TL; Wang, H; Wu, CJ	1

Other Studies

1 other study(ies) available for epigallocatechin gallate and Carcinoma, Lewis Lung

Article	Year
Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia. Cancer letters, 2011, Jun-01, Volume: 305, Issue:1 Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Cachexia; Carcinoma, Lewis Lung; Catechin; Fluorescent Antibody Technique; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases	2011

Article

Year

Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.

Cancer letters, 2011, Jun-01, Volume: 305, Issue:1

Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Cachexia; Carcinoma, Lewis Lung; Catechin; Fluorescent Antibody Technique; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases

2011